BeOne Medicines Ltd
ONCHealthcare|Biotechnology|Switzerland
$298.70
-4.13 (-1.36%)
Tangible Book
$42.27
Graham Number
$97.57
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (314)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lee Chan Henry | SVP, General Counsel | 2026-07-08 | SELL | 664 | $302.46 | $200.8K |
| Wu Xiaobin | President and COO | 2026-06-23 | SELL | 1,292 | $276.26 | $356.9K |
| OYLER JOHN | CEO | 2026-06-23 | SELL | 3,410 | $273.78 | $933.6K |
| Wang Lai | President, Global Head of R&D | 2026-06-23 | SELL | 1,068 | $276.74 | $295.6K |
| Wang Lai | President, Global Head of R&D | 2026-06-16 | SELL | 1,169 | $265.39 | $310.2K |
| Wu Xiaobin | President and COO | 2026-06-16 | SELL | 1,357 | $266.76 | $362K |
| OYLER JOHN | CEO | 2026-06-16 | SELL | 3,693 | $265.55 | $980.7K |
| Lee Chan Henry | SVP, General Counsel | 2026-06-16 | SELL | 590 | $265.98 | $156.9K |
| Ball Titus B. | Principal Accounting Officer | 2026-06-11 | SELL | 169 | $257.2 | $43.5K |
| Wang Lai | President, Global Head of R&D | 2026-06-11 | SELL | 756 | $261 | $197.3K |
| Rosenberg Aaron | CFO | 2026-06-11 | SELL | 631 | $257.74 | $162.6K |
| Wu Xiaobin | President and COO | 2026-06-11 | SELL | 626 | $261.2 | $163.5K |
| Lee Chan Henry | SVP, General Counsel | 2026-06-11 | SELL | 428 | $257.64 | $110.3K |
| OYLER JOHN | CEO | 2026-06-11 | SELL | 1,949 | $257.24 | $501.4K |
| Ball Titus B. | Principal Accounting Officer | 2026-06-08 | SELL | 136 | $271.33 | $36.9K |
| Lee Chan Henry | SVP, General Counsel | 2026-06-08 | SELL | 871 | $270.42 | $235.5K |
| Wang Lai | President, Global Head of R&D | 2026-06-08 | SELL | 1,367 | $269.38 | $368.2K |
| Wu Xiaobin | President and COO | 2026-06-08 | SELL | 1,484 | $269.37 | $399.7K |
| OYLER JOHN | CEO | 2026-06-08 | SELL | 4,940 | $270.56 | $1336.6K |
| Yi Qingqing | Director | 2026-06-01 | SELL | 235 | $279.13 | $65.6K |
| BAKER BROS. ADVISORS LP | Director | 2026-05-22 | SELL | 10,998 | $23.82 | $262K |
| Riva Alessandro | Director | 2026-05-22 | SELL | 212 | $309.51 | $65.6K |
| Dugan Margaret | Director | 2026-05-22 | SELL | 212 | $309.6 | $65.6K |
| Sanders Corazon (Corsee) D. | Director | 2026-05-22 | SELL | 212 | $309.59 | $65.6K |
| Lee Chan Henry | SVP, General Counsel | 2026-05-13 | SELL | 332 | $310.72 | $103.2K |
| Lee Chan Henry | SVP, General Counsel | 2026-04-08 | SELL | 332 | $311.59 | $103.4K |
| Lee Chan Henry | SVP, General Counsel | 2026-03-11 | SELL | 341 | $300 | $102.3K |
| Lee Chan Henry | SVP, General Counsel | 2026-02-04 | SELL | 1,660 | $349.52 | $580.2K |
| Lee Chan Henry | SVP, General Counsel | 2026-01-07 | SELL | 664 | $331.76 | $220.3K |
| OYLER JOHN | CEO | 2025-12-16 | SELL | 100,000 | $306.59 | $30659K |
| Lee Chan Henry | SVP, General Counsel | 2025-12-11 | SELL | 664 | $321.64 | $213.6K |
| Sanders Corazon (Corsee) D. | Director | 2025-11-26 | SELL | 2,627 | $340.9 | $895.5K |
| Wu Xiaobin | President and COO | 2025-11-17 | SELL | 3,991 | $380.43 | $1518.3K |
| Wu Xiaobin | President and COO | 2025-11-13 | SELL | 16,009 | $365.22 | $5846.8K |
| Lee Chan Henry | SVP, General Counsel | 2025-11-12 | SELL | 996 | $349.17 | $347.8K |
| Lee Chan Henry | SVP, General Counsel | 2025-10-08 | SELL | 10,671 | $350.4 | $3739.1K |
| OYLER JOHN | CEO | 2025-09-16 | SELL | 27,803 | $325.71 | $9055.7K |
| Lee Chan Henry | SVP, General Counsel | 2025-09-10 | SELL | 10,006 | $325.53 | $3257.3K |
| Wang Lai | Global Head of R&D | 2025-09-09 | SELL | 5,000 | $350.06 | $1750.3K |
| Sanders Corazon (Corsee) D. | Director | 2025-09-05 | SELL | 2,665 | $337 | $898.1K |
| Ball Titus B. | Principal Accounting Officer | 2025-09-02 | SELL | 122 | $326.76 | $39.9K |
| Wu Xiaobin | President and COO | 2025-08-14 | SELL | 89,794 | $304.56 | $27347.7K |
| Lee Chan Henry | SVP, General Counsel | 2025-08-13 | SELL | 11,013 | $300.45 | $3308.9K |
| Rosenberg Aaron | CFO | 2025-08-01 | SELL | 1,190 | $290.47 | $345.7K |
| Wang Lai | Global Head of R&D | 2025-07-30 | SELL | 4,300 | $302.65 | $1301.4K |
| Lee Chan Henry | SVP, General Counsel | 2025-07-30 | SELL | 920 | $304.6 | $280.2K |
| Wang Lai | Global Head of R&D | 2025-07-18 | SELL | 700 | $300 | $210K |
| OYLER JOHN | CEO | 2025-07-09 | SELL | 27,802 | $253.38 | $7044.5K |
| Wang Xiaodong | Director | 2025-06-24 | SELL | 2,007 | $265.5 | $532.9K |
| Wang Lai | Global Head of R&D | 2025-06-23 | SELL | 1,028 | $260 | $267.3K |
| Wu Xiaobin | President and COO | 2025-06-23 | SELL | 1,363 | $260 | $354.4K |
| OYLER JOHN | CEO | 2025-06-23 | SELL | 3,174 | $261.61 | $830.4K |
| Wang Lai | Global Head of R&D | 2025-06-17 | SELL | 1,647 | $262.11 | $431.7K |
| Wu Xiaobin | President and COO | 2025-06-17 | SELL | 2,173 | $261.27 | $567.7K |
| OYLER JOHN | CEO | 2025-06-17 | SELL | 5,140 | $263.33 | $1353.5K |
| Lee Chan Henry | SVP, General Counsel | 2025-06-16 | SELL | 422 | $266.5 | $112.5K |
| Ball Titus B. | Principal Accounting Officer | 2025-06-11 | SELL | 134 | $258.36 | $34.6K |
| Wang Xiaodong | Director | 2025-06-10 | SELL | 41,760 | $262.82 | $10975.4K |
| Lee Chan Henry | SVP, General Counsel | 2025-06-06 | SELL | 700 | $256.11 | $179.3K |
| Wang Lai | Global Head of R&D | 2025-06-06 | SELL | 1,402 | $252.39 | $353.9K |
| Wu Xiaobin | President and COO | 2025-06-06 | SELL | 1,934 | $253.15 | $489.6K |
| OYLER JOHN | CEO | 2025-06-06 | SELL | 5,127 | $252.77 | $1296K |
| Wang Xiaodong | Director | 2025-05-13 | SELL | 41,760 | $223.5 | $9333.4K |
| Wang Xiaodong | Director | 2025-04-14 | SELL | 41,760 | $242.66 | $10133.5K |
| Wu Xiaobin | President, COO & GM China | 2025-04-01 | SELL | 51,921 | $281.4 | $14610.6K |
| Wang Xiaodong | Director | 2025-03-18 | SELL | 41,760 | $261.28 | $10911.1K |
| OYLER JOHN | CEO | 2025-03-10 | SELL | 41,210 | $242.67 | $10000.4K |
| OYLER JOHN | CEO | 2025-03-07 | SELL | 58,590 | $249.13 | $14596.5K |
| OYLER JOHN | CEO | 2025-03-06 | SELL | 40,109 | $259.15 | $10394.2K |
| Wu Xiaobin | President, COO & GM China | 2025-03-05 | SELL | 51,921 | $261.59 | $13582K |
| Wang Xiaodong | Director | 2025-03-04 | SELL | 8,146 | $254.58 | $2073.8K |
| OYLER JOHN | CEO | 2025-03-03 | SELL | 101,000 | $244.3 | $24674.3K |
| BAKER BROS. ADVISORS LP | Director | 2025-02-28 | SELL | 732,827 | $260 | $190535K |
| Lee Chan Henry | SVP, General Counsel | 2025-02-27 | SELL | 1,205 | $275 | $331.4K |
| Wang Lai | Global Head of R&D | 2025-02-21 | SELL | 5,000 | $257.23 | $1286.2K |
| Lee Chan Henry | SVP, General Counsel | 2025-02-21 | SELL | 1,202 | $258.04 | $310.2K |
| Wu Xiaobin | President, COO & GM China | 2025-02-20 | SELL | 51,921 | $240.46 | $12484.9K |
| Wang Xiaodong | Director | 2025-02-04 | SELL | 41,760 | $225.69 | $9424.8K |
| Wang Xiaodong | Director | 2025-01-07 | SELL | 41,760 | $176.5 | $7370.6K |
| Wang Xiaodong | Director | 2024-12-10 | SELL | 41,760 | $186.9 | $7804.9K |
| BAKER BROS. ADVISORS LP | Director | 2024-12-09 | SELL | 1,037,017 | $187.27 | $194202.2K |
| HHLR ADVISORS, LTD. | 10% Owner | 2024-12-02 | SELL | 17,842,500 | $200 | $3568500K |
| Wang Xiaodong | Director | 2024-11-26 | SELL | 48,351 | $190.08 | $9190.6K |
| OYLER JOHN | CEO | 2024-10-08 | SELL | 16,175 | $232.22 | $3756.2K |
| Lee Chan Henry | SVP, General Counsel | 2024-09-30 | SELL | 1,202 | $237.1 | $285K |
| Wang Lai | Global Head of R&D | 2024-09-27 | SELL | 5,000 | $220.35 | $1101.8K |
| Wu Xiaobin | President, COO & GM China | 2024-09-19 | SELL | 5,000 | $200.12 | $1000.6K |
| Wu Xiaobin | President, COO & GM China | 2024-09-03 | SELL | 5,556 | $189.65 | $1053.7K |
| Ball Titus B. | Principal Accounting Officer | 2024-09-03 | SELL | 137 | $189.94 | $26K |
| Lee Chan Henry | SVP, General Counsel | 2024-07-30 | SELL | 834 | $160.57 | $133.9K |
| Wang Julia Aijun | CFO | 2024-07-01 | SELL | 472 | $143.9 | $67.9K |
| Wang Julia Aijun | CFO | 2024-06-24 | SELL | 899 | $155.66 | $139.9K |
| Wang Lai | Global Head of R&D | 2024-06-24 | SELL | 1,064 | $159.8 | $170K |
| Wu Xiaobin | President, COO & GM China | 2024-06-24 | SELL | 1,459 | $159.79 | $233.1K |
| OYLER JOHN | CEO | 2024-06-24 | SELL | 2,789 | $159.58 | $445.1K |
| Wang Lai | Global Head of R&D | 2024-06-18 | SELL | 2,341 | $157.27 | $368.2K |
| Wu Xiaobin | President, COO & GM China | 2024-06-18 | SELL | 3,254 | $155.26 | $505.2K |
| OYLER JOHN | CEO | 2024-06-17 | SELL | 1,281 | $159.35 | $204.1K |
| Wang Julia Aijun | CFO | 2024-06-17 | SELL | 916 | $159.04 | $145.7K |
| Lee Chan Henry | SVP, General Counsel | 2024-06-17 | SELL | 439 | $159.35 | $70K |
| OYLER JOHN | CEO | 2024-04-11 | SELL | 50,000 | $149.5 | $7475K |
| OYLER JOHN | CEO | 2024-03-13 | SELL | 50,000 | $167.36 | $8368K |
| Wang Julia Aijun | CFO | 2024-02-29 | SELL | 397 | $167.08 | $66.3K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2023-11-14 | SELL | 1,100,000 | $180.5 | $198550K |
| Lee Chan Henry | SVP, General Counsel | 2023-07-31 | SELL | 791 | $216.26 | $171.1K |
| Wang Julia Aijun | CFO | 2023-07-03 | SELL | 472 | $179.55 | $84.7K |
| Wang Lai | Global Head of R&D | 2023-06-26 | SELL | 1,108 | $181.92 | $201.6K |
| Wu Xiaobin | President, COO & GM China | 2023-06-26 | SELL | 1,495 | $182.37 | $272.6K |
| Wang Julia Aijun | CFO | 2023-06-23 | SELL | 840 | $182.85 | $153.6K |
| Sanders Corazon (Corsee) D. | Director | 2023-06-23 | SELL | 578 | $182.32 | $105.4K |
| Wang Lai | Global Head of R&D | 2023-06-20 | SELL | 1,325 | $192.42 | $255K |
| Wang Julia Aijun | CFO | 2023-06-20 | SELL | 190 | $192.54 | $36.6K |
| Wu Xiaobin | President, COO & GM China | 2023-06-20 | SELL | 1,753 | $192.44 | $337.3K |
| HHLR ADVISORS, LTD. | 10% Owner | 2023-06-14 | SELL | 1,198,128 | $188.88 | $226302.4K |
| HHLR ADVISORS, LTD. | 10% Owner | 2023-06-12 | SELL | 2,956,689 | $201.98 | $597192K |
| Wang Lai | Global Head of R&D | 2023-06-07 | SELL | 462 | $224.74 | $103.8K |
| Wu Xiaobin | President, COO & GM China | 2023-06-07 | SELL | 3,291 | $224.73 | $739.6K |
| Wu Xiaobin | President, COO & GM China | 2023-05-08 | SELL | 7,000 | $253.72 | $1776K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2023-03-08 | SELL | 67,635 | $226.03 | $15287.5K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2023-01-12 | SELL | 5,000 | $260.52 | $1302.6K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2023-01-11 | SELL | 5,000 | $251.36 | $1256.8K |
| OYLER JOHN | CEO | 2023-01-10 | SELL | 20,391 | $248.51 | $5067.4K |
| OYLER JOHN | CEO | 2022-12-29 | SELL | 9,609 | $224.43 | $2156.5K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2022-12-13 | SELL | 3,013 | $211.33 | $636.7K |
| OYLER JOHN | CEO | 2022-11-15 | SELL | 29,928 | $206.84 | $6190.3K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2022-11-15 | SELL | 1,987 | $210.14 | $417.5K |
| OYLER JOHN | CEO | 2022-09-21 | SELL | 50,000 | $152.13 | $7606.5K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2022-08-08 | SELL | 16,060 | $196.65 | $3158.2K |
| Wang Julia Aijun | CFO | 2022-07-01 | SELL | 317 | $158.5 | $50.2K |
| Wang Julia Aijun | CFO | 2022-07-01 | SELL | 295 | $158.5 | $46.8K |
| Wang Lai | Global Head of R&D | 2022-06-27 | SELL | 458 | $177.32 | $81.2K |
| Wang Lai | Global Head of R&D | 2022-06-21 | SELL | 1,168 | $145.35 | $169.8K |
| Wu Xiaobin | President, COO & GM China | 2022-06-21 | SELL | 1,588 | $142.63 | $226.5K |
| Wang Julia Aijun | CFO | 2022-06-17 | SELL | 161 | $136.64 | $22K |
| Wang Lai | Global Head of R&D | 2022-06-06 | SELL | 660 | $142 | $93.7K |
| Wu Xiaobin | President, COO & GM China | 2022-06-06 | SELL | 3,410 | $141.99 | $484.2K |
| Wu Xiaobin | President, COO & GM China | 2022-05-05 | SELL | 6,725 | $164.35 | $1105.3K |
| Huang Jane | CMO, Hematology | 2021-12-14 | SELL | 1,500 | $278.14 | $417.2K |
| Huang Jane | CMO, Hematology | 2021-12-01 | SELL | 1,049 | $359.86 | $377.5K |
| Huang Jane | CMO, Hematology | 2021-11-17 | SELL | 1,500 | $381.34 | $572K |
| Wu Xiaobin | President, COO & GM China | 2021-11-09 | SELL | 10,000 | $358.27 | $3582.7K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2021-11-08 | SELL | 4,500 | $350.04 | $1575.2K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2021-11-08 | SELL | 4,500 | $349.81 | $1574.1K |
| Huang Jane | CMO, Hematology | 2021-10-19 | SELL | 1,500 | $372.78 | $559.2K |
| Huang Jane | CMO, Hematology | 2021-09-20 | SELL | 6,000 | $397.96 | $2387.8K |
| OYLER JOHN | CEO | 2021-09-15 | SELL | 411,838 | $82.04 | $33787.2K |
| Huang Jane | CMO, Hematology | 2021-09-13 | SELL | 12,901 | $358.14 | $4620.4K |
| AMGEN INC | 10% Owner | 2021-09-10 | BUY | 165,529 | $302.06 | $49999.7K |
| OYLER JOHN | CEO | 2021-09-02 | SELL | 288,639 | $109.77 | $31683.9K |
| Huang Jane | CMO, Hematology | 2021-09-02 | SELL | 1,087 | $318.88 | $346.6K |
| OYLER JOHN | CEO | 2021-08-05 | SELL | 125,309 | $132.34 | $16583.4K |
| OYLER JOHN | CEO | 2021-08-03 | SELL | 83,359 | $182.37 | $15202.2K |
| OYLER JOHN | CEO | 2021-07-22 | SELL | 69,216 | $71.82 | $4971.1K |
| OYLER JOHN | CEO | 2021-07-21 | SELL | 70,855 | $152.13 | $10779.2K |
| Huang Jane | CMO, Hematology | 2021-07-15 | SELL | 21,000 | $332.42 | $6980.8K |
| OYLER JOHN | CEO | 2021-07-08 | SELL | 67,481 | $94.83 | $6399.2K |
| OYLER JOHN | CEO | 2021-07-07 | SELL | 123,821 | $117.22 | $14514.3K |
| Wu Xiaobin | President, COO & GM China | 2021-07-06 | SELL | 10,180 | $325.53 | $3313.9K |
| Huang Jane | CMO, Hematology | 2021-06-29 | SELL | 1,925 | $354.97 | $683.3K |
| Liang Howard | CFO & Chief Strategy Officer | 2021-06-28 | SELL | 446 | $365 | $162.8K |
| Wang Lai | Global Head of R&D | 2021-06-28 | SELL | 455 | $362.48 | $164.9K |
| Huang Jane | CMO, Hematology | 2021-06-18 | SELL | 469 | $325.66 | $152.7K |
| Liang Howard | CFO & Chief Strategy Officer | 2021-06-18 | SELL | 486 | $325.89 | $158.4K |
| Wu Xiaobin | President, COO & GM China | 2021-06-18 | SELL | 1,156 | $330.93 | $382.6K |
| Wang Lai | Global Head of R&D | 2021-06-18 | SELL | 802 | $331.15 | $265.6K |
| Chen Timothy Yung-Cheng | Director | 2021-06-10 | SELL | 6,000 | $351.67 | $2110K |
| Wu Xiaobin | President, COO & GM China | 2021-06-07 | SELL | 3,398 | $352.54 | $1197.9K |
| Liang Howard | CFO & Chief Strategy Officer | 2021-06-07 | SELL | 650 | $354.16 | $230.2K |
| Wang Lai | Global Head of R&D | 2021-06-07 | SELL | 656 | $354.26 | $232.4K |
| Huang Jane | CMO, Hematology | 2021-06-07 | SELL | 603 | $351.55 | $212K |
| Huang Jane | CMO, Hematology | 2021-06-01 | SELL | 2,040 | $357.98 | $730.3K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2021-05-10 | SELL | 3,394 | $300.46 | $1019.8K |
| Wu Xiaobin | President, COO & GM China | 2021-05-03 | SELL | 6,715 | $343 | $2303.2K |
| Huang Jane | CMO, Hematology | 2021-03-29 | SELL | 1,500 | $324 | $486K |
| Huang Jane | CMO, Hematology | 2021-02-26 | SELL | 1,500 | $320.73 | $481.1K |
| Huang Jane | CMO, Hematology | 2021-01-29 | SELL | 1,500 | $322.99 | $484.5K |
| Liang Howard | CFO & Chief Strategy Officer | 2021-01-15 | SELL | 14,000 | $344.85 | $4827.9K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2021-01-04 | SELL | 121,154 | $220.5 | $26714.5K |
| Huang Jane | CMO, Hematology | 2020-12-29 | SELL | 1,500 | $249.13 | $373.7K |
| Liang Howard | CFO & Chief Strategy Officer | 2020-12-14 | SELL | 91,900 | $229.04 | $21048.8K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2020-12-04 | SELL | 1,511,546 | $220.5 | $333295.9K |
| Huang Jane | CMO, Hematology | 2020-11-30 | SELL | 1,500 | $267.82 | $401.7K |
| Huang Jane | CMO, Hematology | 2020-10-29 | SELL | 1,500 | $300.06 | $450.1K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-10-16 | SELL | 5,000 | $320 | $1600K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-10-05 | SELL | 5,000 | $300 | $1500K |
| Wu Xiaobin | President & GM China | 2020-10-05 | SELL | 4,000 | $300 | $1200K |
| Liang Howard | CFO & Chief Strategy Officer | 2020-10-05 | SELL | 14,000 | $299.6 | $4194.4K |
| OYLER JOHN | CEO | 2020-09-29 | SELL | 54,303 | $280.39 | $15226K |
| Huang Jane | CMO, Hematology | 2020-09-29 | SELL | 1,500 | $280.38 | $420.6K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-09-25 | SELL | 5,000 | $280.42 | $1402.1K |
| Wu Xiaobin | President & GM China | 2020-09-25 | SELL | 4,000 | $280.35 | $1121.4K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-09-17 | SELL | 5,000 | $260.27 | $1301.4K |
| Wu Xiaobin | President & GM China | 2020-09-17 | SELL | 4,000 | $260.33 | $1041.3K |
| OYLER JOHN | CEO | 2020-09-16 | SELL | 81,228 | $253.46 | $20588K |
| Liang Howard | CFO & Chief Strategy Officer | 2020-09-14 | SELL | 14,000 | $250.27 | $3503.8K |
| Huang Jane | CMO, Hematology | 2020-09-03 | SELL | 3,128 | $233.07 | $729K |
| OYLER JOHN | CEO | 2020-09-02 | SELL | 61,042 | $233.21 | $14235.6K |
| Huang Jane | CMO, Hematology | 2020-08-28 | SELL | 3,000 | $242.21 | $726.6K |
| OYLER JOHN | CEO | 2020-08-21 | SELL | 92,177 | $237.06 | $21851.5K |
| OYLER JOHN | CEO | 2020-08-14 | SELL | 42,968 | $212.71 | $9139.7K |
| Chen Timothy Yung-Cheng | Director | 2020-08-12 | SELL | 7,000 | $212.92 | $1490.4K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-08-10 | SELL | 4,000 | $211.06 | $844.2K |
| OYLER JOHN | CEO | 2020-08-05 | SELL | 17,254 | $223.27 | $3852.3K |
| OYLER JOHN | CEO | 2020-08-04 | SELL | 40,559 | $221.27 | $8974.5K |
| Huang Jane | CMO, Hematology | 2020-07-29 | SELL | 3,000 | $209.93 | $629.8K |
| OYLER JOHN | CEO | 2020-07-22 | SELL | 27,748 | $238.34 | $6613.5K |
| OYLER JOHN | CEO | 2020-07-21 | SELL | 55,175 | $251.84 | $13895.3K |
| Wu Xiaobin | President & GM China | 2020-07-20 | SELL | 3,300 | $249.22 | $822.4K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-07-20 | SELL | 17,000 | $251.51 | $4275.7K |
| Wu Xiaobin | President & GM China | 2020-07-15 | SELL | 5,700 | $230 | $1311K |
| OYLER JOHN | CEO | 2020-07-08 | SELL | 53,914 | $199.12 | $10735.4K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-07-07 | SELL | 6,000 | $200 | $1200K |
| Huang Jane | CMO, Hematology | 2020-07-07 | SELL | 3,921 | $200 | $784.2K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-07-01 | SELL | 4,847 | $190.75 | $924.6K |
| OYLER JOHN | CEO | 2020-07-01 | SELL | 5,251 | $191.85 | $1007.4K |
| Huang Jane | CMO, Hematology | 2020-06-29 | SELL | 4,014 | $195.73 | $785.7K |
| Liang Howard | CFO & Chief Strategy Officer | 2020-06-29 | SELL | 300 | $191.23 | $57.4K |
| OYLER JOHN | CEO | 2020-06-24 | SELL | 39,732 | $185.9 | $7386.2K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-06-23 | SELL | 11,000 | $184.09 | $2025K |
| OYLER JOHN | CEO | 2020-06-10 | SELL | 900 | $175.07 | $157.6K |
| Liang Howard | CFO & Chief Strategy Officer | 2020-06-08 | SELL | 453 | $170.84 | $77.4K |
| Wu Xiaobin | President & GM China | 2020-06-08 | SELL | 2,800 | $170.83 | $478.3K |
| Huang Jane | CMO, Hematology | 2020-06-08 | SELL | 631 | $170.84 | $107.8K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-06-08 | SELL | 6,000 | $170.91 | $1025.5K |
| Huang Jane | CMO, Hematology | 2020-05-29 | SELL | 1,500 | $163.86 | $245.8K |
| Glazer Donald W. | Director | 2020-05-19 | SELL | 10,000 | $169.84 | $1698.4K |
| OYLER JOHN | CEO | 2020-05-01 | SELL | 4,635 | $141.43 | $655.5K |
| Wu Xiaobin | President & GM China | 2020-05-01 | SELL | 7,024 | $141.33 | $992.7K |
| Huang Jane | CMO, Hematology | 2020-04-29 | SELL | 1,500 | $162.3 | $243.5K |
| Huang Jane | CMO, Hematology | 2020-04-16 | SELL | 1,500 | $160 | $240K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2020-03-04 | SELL | 5,000 | $157.14 | $785.7K |
| Huang Jane | CMO, Hematology | 2020-02-18 | SELL | 1,500 | $170.25 | $255.4K |
| Huang Jane | CMO, Hematology | 2020-01-21 | SELL | 1,500 | $170.69 | $256K |
| OYLER JOHN | CEO | 2019-12-17 | SELL | 62,259 | $160.62 | $10000K |
| Huang Jane | CMO, Hematology | 2019-12-16 | SELL | 1,500 | $165.14 | $247.7K |
| Liang Howard | CFO & Chief Strategy Officer | 2019-11-18 | SELL | 25,000 | $194.34 | $4858.5K |
| Huang Jane | CMO, Hematology | 2019-11-18 | SELL | 1,500 | $194.49 | $291.7K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2019-11-15 | SELL | 13,000 | $194.63 | $2530.2K |
| Wu Xiaobin | President & GM China | 2019-11-15 | SELL | 1,000 | $202.05 | $202.1K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2019-11-04 | SELL | 2,000 | $180 | $360K |
| Huang Jane | CMO, Hematology | 2019-11-04 | SELL | 32,900 | $190.46 | $6266.1K |
| Chen Timothy Yung-Cheng | Director | 2019-11-04 | SELL | 8,000 | $189.86 | $1518.9K |
| Wu Xiaobin | President & GM China | 2019-11-01 | SELL | 1,000 | $180 | $180K |
| Huang Jane | CMO, Hematology | 2019-09-04 | SELL | 2,944 | $144.03 | $424K |
| Chen Timothy Yung-Cheng | Director | 2019-08-23 | SELL | 8,614 | $144.96 | $1248.7K |
| Huang Jane | CMO, Hematology | 2019-08-12 | SELL | 2,500 | $134.74 | $336.9K |
| Huang Jane | CMO, Hematology | 2019-07-29 | SELL | 10,130 | $134.54 | $1362.9K |
| OYLER JOHN | CEO | 2019-07-08 | SELL | 3,106 | $126.87 | $394.1K |
| Wang Xiaodong | Chair, Scientific Advisory Brd | 2019-07-01 | SELL | 4,847 | $126.46 | $613K |
| Huang Jane | CMO, Hematology | 2019-06-27 | SELL | 430 | $124.52 | $53.5K |
| Liang Howard | CFO & Chief Strategy Officer | 2019-06-27 | SELL | 5,876 | $9.47 | $55.6K |
| Huang Jane | CMO, Hematology | 2019-05-21 | SELL | 2,500 | $130.07 | $325.2K |
| Liang Howard | CFO & Chief Strategy Officer | 2019-05-21 | SELL | 23,200 | $130.21 | $3020.9K |
| Glazer Donald W. | Director | 2019-05-13 | SELL | 15,027 | $125.11 | $1880K |
| Liang Howard | CFO & Chief Strategy Officer | 2019-05-06 | SELL | 1,800 | $130.01 | $234K |
| Wu Xiaobin | President & GM China | 2019-05-01 | SELL | 5,955 | $124.52 | $741.5K |
| OYLER JOHN | CEO | 2019-05-01 | SELL | 2,824 | $125.18 | $353.5K |
| Huang Jane | CMO, Hematology | 2019-04-08 | SELL | 14,130 | $142.77 | $2017.3K |
| Glazer Donald W. | Director | 2019-03-14 | SELL | 14,973 | $136.1 | $2037.8K |
| Huang Jane | CMO, Hematology | 2019-03-11 | SELL | 2,636 | $130.28 | $343.4K |
| OYLER JOHN | CEO | 2019-03-06 | SELL | 25,499 | $151.73 | $3869K |
| Wang Xiaodong | Director | 2019-03-01 | SELL | 5,000 | $146.82 | $734.1K |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-12-18 | SELL | 20,000 | $133.68 | $2673.6K |
| OYLER JOHN | CEO | 2018-12-10 | SELL | 4,138 | $135.78 | $561.9K |
| Wang Xiaodong | Director | 2018-12-03 | SELL | 5,000 | $152.41 | $762.1K |
| OYLER JOHN | CEO | 2018-11-28 | SELL | 29,195 | $143.66 | $4194.2K |
| Huang Jane | CMO, Hematology | 2018-11-26 | SELL | 3,000 | $139.58 | $418.7K |
| Wang Xiaodong | Director | 2018-11-19 | SELL | 5,000 | $124.3 | $621.5K |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | SELL | 40,000 | $120.2 | $4808K |
| Huang Jane | CMO, Hematology | 2018-09-04 | SELL | 2,911 | $174.6 | $508.3K |
| Glazer Donald W. | Director | 2018-08-30 | SELL | 2,000 | $179 | $358K |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-08-23 | SELL | 5,769 | $169.12 | $975.7K |
| Wang Xiaodong | Director | 2018-08-13 | SELL | 3,449 | $158.77 | $547.6K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2018-08-02 | BUY | 5,814,100 | $108 | $627922.8K |
| OYLER JOHN | CEO, 10% Owner | 2018-07-16 | SELL | 2,550 | $164.12 | $418.5K |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | SELL | 40,000 | $160.27 | $6410.8K |
| OYLER JOHN | CEO, 10% Owner | 2018-03-02 | SELL | 99,000 | $145.63 | $14417.4K |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | SELL | 10,000 | $146.88 | $1468.8K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2018-01-18 | BUY | 1,980,198 | $101 | $200000K |
| OYLER JOHN | CEO, 10% Owner | 2017-12-26 | SELL | 20,137 | $96.46 | $1942.4K |
| Huang Jane | CMO, Hematology | 2017-12-21 | SELL | 1,000 | $98 | $98K |
| Huang Jane | CMO, Hematology | 2017-12-13 | SELL | 1,500 | $94.25 | $141.4K |
| OYLER JOHN | CEO, 10% Owner | 2017-12-08 | SELL | 144,000 | $93.95 | $13528.8K |
| Huang Jane | CMO, Hematology | 2017-12-04 | SELL | 1,100 | $86 | $94.6K |
| OYLER JOHN | CEO, 10% Owner | 2017-11-29 | SELL | 85,906 | $84.66 | $7272.8K |
| Huang Jane | CMO, Hematology | 2017-11-20 | SELL | 1,600 | $86.25 | $138K |
| OYLER JOHN | CEO, 10% Owner | 2017-11-15 | SELL | 150,957 | $80.5 | $12152K |
| Peterson Amy C. | CMO, Immuno-oncology | 2017-11-13 | SELL | 3,601 | $82.96 | $298.7K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2017-08-11 | BUY | 176,056 | $71 | $12500K |
| Wang Xiaodong | Director | 2017-07-12 | SELL | 20,000 | $72.44 | $1448.8K |
| Glazer Donald W. | Director | 2017-07-10 | SELL | 10,810 | $72.15 | $779.9K |
| OYLER JOHN | CEO, 10% Owner | 2017-07-06 | SELL | 219,400 | $64.82 | $14221.5K |
| Wang Xiaodong | Director | 2017-06-28 | SELL | 35,000 | $44.95 | $1573.3K |
| OYLER JOHN | CEO, 10% Owner | 2017-06-23 | SELL | 98,500 | $44.16 | $4349.8K |
| Wang Xiaodong | Director | 2017-06-02 | SELL | 5,539 | $40 | $221.6K |
| Wang Xiaodong | Director | 2017-05-04 | SELL | 14,461 | $40.8 | $590K |
| OYLER JOHN | CEO, 10% Owner | 2017-05-01 | SELL | 36,149 | $40.47 | $1463K |
| Wang Xiaodong | Director | 2017-04-05 | SELL | 11,650 | $36.83 | $429.1K |
| Wang Xiaodong | Director | 2017-03-24 | SELL | 38,107 | $36.96 | $1408.4K |
| OYLER JOHN | CEO, 10% Owner | 2017-03-20 | SELL | 31,989 | $39.39 | $1260K |
| Wang Xiaodong | Director | 2017-03-10 | SELL | 36,892 | $39.89 | $1471.6K |
| OYLER JOHN | CEO, 10% Owner | 2017-03-06 | SELL | 108,999 | $40.91 | $4459.1K |
| Wang Xiaodong | Director | 2017-02-27 | SELL | 38,351 | $38.19 | $1464.6K |
| OYLER JOHN | CEO, 10% Owner | 2017-02-21 | SELL | 64,963 | $40.55 | $2634.2K |
| Wang Xiaodong | Director | 2016-11-23 | SELL | 93,750 | $32 | $3000K |
| Malley Thomas | Director | 2016-11-23 | BUY | 30,000 | $32 | $960K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2016-11-18 | BUY | 1,760,495 | $32 | $56335.8K |
| Glazer Donald W. | Director | 2016-09-28 | SELL | 41,463 | $30.66 | $1271.3K |
| Glazer Donald W. | Director | 2016-09-27 | SELL | 47,149 | $29.61 | $1396.1K |
| Glazer Donald W. | Director | 2016-09-23 | SELL | 36,443 | $31.02 | $1130.5K |
| Glazer Donald W. | Director | 2016-09-21 | SELL | 67,252 | $31.42 | $2113.1K |
| Liang Howard | CFO & Chief Strategy Officer | 2016-02-08 | BUY | 65,000 | $1.85 | $120.3K |
| Yuan RuiRong | Chief Medical Officer | 2016-02-08 | BUY | 130,000 | $1.85 | $240.5K |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 2016-02-08 | BUY | 1,912,680 | $24 | $45904.3K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked